# Metformin Hydrochloride vs. Placebo in Overweight or Obese Patients at Elevated Risk for Breast Cancer

> **NCT01793948** · EARLY_PHASE1 · COMPLETED · sponsor: **Anna Maria Storniolo** · enrollment: 24 (actual)

## Conditions studied

- Breast Cancer
- Obesity

## Interventions

- **DRUG:** metformin hydrochloride
- **OTHER:** placebo
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT01793948
- **Lead sponsor:** Anna Maria Storniolo
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04-16
- **Primary completion:** 2018-01-09
- **Final completion:** 2018-01-09
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2018-03-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01793948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01793948, "Metformin Hydrochloride vs. Placebo in Overweight or Obese Patients at Elevated Risk for Breast Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01793948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*